Bisphosphonates are structural analogs of pyrophoscloning, subtractive hybridization, candidate molecules, phate that contain phosphorus-carbon-phosphorus RT-PCR of Drosophila morphogens, and the use of (P-C-P) bonds instead of phosphorus-oxygen-phosphoexpressed sequence tags (ESTs). The present identirus bonds (Fleisch, 1997) . Bisphosphonates bind with fication of a novel soluble TNF receptor increasing high affinity to bone mineral crystals and inhibit the disbone density, by decreasing bone resorption, has been solution of minerals. Furthermore the P-C-P bonds in achieved by researchers at Amgen based on ESTs (Sibisphosphonates are resistant to enzymatic hydrolysis monet et al., 1997). The authors of this report initially by acid and alkaline phosphatases or pyrophosphatase. identified a novel member of the TNF receptor (TNFR)
These properties explain the fact that bisphosphonates family from the fetal rat intestine. The novel cDNA enact as potent inhibitors of bone resorption in vivo. As codes a 401-amino acid protein and appears to be a such, they have been extensively studied for possible secreted glycoprotein with a leader sequence. The therapeutic application in Paget's disease of bone, hyamino half of the sequence is related closely to TNFR-2 percalcemia of malignancy, and osteolytic metastases and CD40. The protein, however, lacks sequence homol- (Fleisch, 1997) . Also, ovariectomy-induced bone loss ogies to known TNFRs in the carboxy-terminal half.
can be prevented by bisphosphonates, suggesting therPulse-chase experiments demonstrated the dimeric naapeutic use in osteoporosis. Because osteoprotegerin ture of the secreted protein of a molecular mass of 110 also blocks bone resorption in vivo, it is conceivable kDa and is a glycoprotein. It is noteworthy that it is that osteoprotegerin may also have a clinical utility in expressed in intestine, liver, kidney, lung, and calvaria.
osteoporosis. Only time and more clinical studies will Calcium and phosphate transport and homeostasis is tell if osteoprotegerin will be another winner, such as a collaborative venture of intestine, kidney, and bone.
erythropoietin, for Amgen. It is interesting to note that this novel gene product is highly expressed by the same triad of tissues. It is likely Selected Reading that there are both local and systemic functions for this Aderka, D. (1996) . Cytokine Growth Factor Rev. 7, 231-240.
protein. In humans and mouse, it is also detected in the placenta. In situ hybridization revealed localization in Baron, R. (1993) . In Physiology and Pharmacology of Bone, G.R.
